Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
Clinical trial NCT06054113 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06054113
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-23
- Primary completion
- 2026-01-05
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.